Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Grandview Hospital
mi
from
Dayton, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Veterans Affairs Medical Center - Dayton
mi
from
Dayton, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Veterans Affairs Medical Center - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Middletown Regional Hospital
mi
from
Middletown, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Middletown Regional Hospital
mi
from
Middletown, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Geisinger Medical Center
mi
from
Danville, PA
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Geisinger Medical Group - Scenery Park
mi
from
State College, PA
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Geisinger Medical Group - Scenery Park
mi
from
State College, PA
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Click here to add this to my saved trials
Post-treatment Care of Breast Cancer Survivors
Post-treatment Care of Breast Cancer Survivors
Status: Enrolling
Updated:  7/14/2015
Columbia Unviersity Medical Center
mi
from
New York, NY
Post-treatment Care of Breast Cancer Survivors
Post-treatment Care of Breast Cancer Survivors
Status: Enrolling
Updated: 7/14/2015
Columbia Unviersity Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated:  7/14/2015
Yale University
mi
from
New Haven, CT
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated: 7/14/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated:  7/14/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Status: Enrolling
Updated: 7/14/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Personalized Treatment Selection for Metastatic Breast Cancer
Personalized Treatment Selection for Metastatic Breast Cancer
Status: Enrolling
Updated:  7/16/2015
UT MD Anderson Cancer Center
mi
from
Houston, TX
Personalized Treatment Selection for Metastatic Breast Cancer
Personalized Treatment Selection for Metastatic Breast Cancer
Status: Enrolling
Updated: 7/16/2015
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Eugene, OR
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Eugene, OR
Click here to add this to my saved trials
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach
Status: Enrolling
Updated:  7/17/2015
Epic Imaging
mi
from
Portland, OR
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach
Status: Enrolling
Updated: 7/17/2015
Epic Imaging
mi
from
Portland, OR
Click here to add this to my saved trials
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach
Status: Enrolling
Updated:  7/17/2015
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach
Status: Enrolling
Updated: 7/17/2015
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
DCH Cancer Treatment Center
mi
from
Tuscaloosa, AL
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
DCH Cancer Treatment Center
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
Beverly Oncology
mi
from
Montebello, CA
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
Beverly Oncology
mi
from
Montebello, CA
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
Florida Radiation Oncology Group
mi
from
Orange Park, FL
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
Florida Radiation Oncology Group
mi
from
Orange Park, FL
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
St Elizabeth's and Memorial Cancer Center
mi
from
Swansea, IL
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
St Elizabeth's and Memorial Cancer Center
mi
from
Swansea, IL
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
Cancer Institute of Cape Girardeau, LLC
mi
from
Cape Girardeau, MO
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
Cancer Institute of Cape Girardeau, LLC
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
AtlantiCare Cancer Care Institute
mi
from
Galloway, NJ
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
AtlantiCare Cancer Care Institute
mi
from
Galloway, NJ
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
Nazha Cancer Center
mi
from
Northfield, NJ
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
Nazha Cancer Center
mi
from
Northfield, NJ
Click here to add this to my saved trials
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated:  7/17/2015
Dallas Surgical Group / Northpoint Cancer Center
mi
from
Dallas, TX
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Electronic Xoft Intersociety Brachytherapy Trial
Status: Enrolling
Updated: 7/17/2015
Dallas Surgical Group / Northpoint Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Mills Peninsula Hospital
mi
from
San Mateo, CA
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Mills Peninsula Hospital
mi
from
San Mateo, CA
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Wellstar-Kennestone Cancer Center
mi
from
Marietta, GA
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Wellstar-Kennestone Cancer Center
mi
from
Marietta, GA
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Rush University Medical Center
mi
from
Chicago, IL
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Little Company of Mary Hospital
mi
from
Evergreen Park, IL
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Little Company of Mary Hospital
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Holy Cross Medical Center
mi
from
Silver Spring, MD
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Holy Cross Medical Center
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Beth Israel Med Ctr
mi
from
New York, NY
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Dickstein Cancer Center- White Plains Hospital
mi
from
White Plains, NY
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Dickstein Cancer Center- White Plains Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Oklahoma University Health Science Center
mi
from
Oklahoma City, OK
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Oklahoma University Health Science Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Rhode Island Hospital
mi
from
Providence, RI
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated:  7/17/2015
Swedish Cancer Institute
mi
from
Seattle, WA
Post Market Study Using the Xoft Axxent System
Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Status: Enrolling
Updated: 7/17/2015
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
Pre-surgical Phase IIb Trial of Transdermal 4-Hydroxytamoxifen vs. Oral Tamoxifen in Women With Ductal Carcinoma in Situ of the Breast
Status: Enrolling
Updated:  7/18/2015
Northwestern University
mi
from
Chicago, IL
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
Pre-surgical Phase IIb Trial of Transdermal 4-Hydroxytamoxifen vs. Oral Tamoxifen in Women With Ductal Carcinoma in Situ of the Breast
Status: Enrolling
Updated: 7/18/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials